Copyright 2025 The Associated Press. All Rights Reserved. Leverkusen’s head coach Xabi Alonso looks on ahead of the German Bundesliga soccer match between Borussia ...

Although Bayer’s top-selling drug Xarelto lost market exclusivity in most geographies in 2024, the company still predicts it will see strong growth from the pharma business unit beginning in 2027.

Bayer’s Monsanto unit stopped making toxic polychlorinated biphenyls (PCBs) a half century ago, but the legal fallout lingers even as many of the building materials made with the chemicals are ...

Bayer AG’s Monsanto unit stopped making toxic PCBs a half century ago, but the legal fallout lingers even as many of the building materials made with the chemicals are no longer used in US homes ...

(Reuters) -A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals known as PCBs at a Seattle-area school, but found the company ...

Trial was the latest over harm tied to school outside Seattle Company vows appeal of verdict and ‘excessive’ damages awarded Bayer AG was told by a jury to pay $100 million to four people at a Seattle ...

In a significant legal ruling, Bayer AG has been ordered by a Washington state jury to pay $100 million to four individuals who claim they suffered health issues due to exposure to polychlorinated ...

Jury Rules Bayer (Monsanto) Must Pay $100M in Trial Over PCBs in Washington School. Bayer has been ordered to pay $100 million to four individuals who claim they suffered health issues due to exposure ...

Jury Orders Bayer to Pay $100 Million Over PCBs in Washington School By Brendan Pierson and Dietrich Knauth (Reuters) -A Washington jury on Tuesday ordered Bayer to pay $100 million to four people ...

Bayer has signed a deal with Canada-based Smart Earth Camelina Corp., whereby Bayer has acquired the company’s camelina germplasm, intellectual property and materials to expand its global leadership ...

Bayer argues PCB levels were safe, blames school for ignoring warnings Previous trials resulted in over $1.5 billion in verdicts Jan 14 (Reuters) - A Washington jury on Tuesday ordered Bayer ...

Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell ...